Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
inflammatory5866 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A11573 | 30834274 | Biomed Res Int | Frequency of Hepatobiliary Manifestations and Concomitant Liver Disease in Inflammatory Bowel Disease Patients. | 2019 | Details |
| A11576 | 30833154 | Endocrinol Diabetes Nutr (Engl Ed) | Inflammatory stress and altered angiogenesis evoked by very high-fat diets in mouse liver. | 2019 | Details |
| A11579 | 30832423 | Microorganisms | Microbial Population Changes and Their Relationship with Human Health and Disease. | 2019 | Details |
| A11586 | 30828861 | J Gastroenterol Hepatol | Adipose tissue-derived stem cells prevent fibrosis in murine steatohepatitis by suppressing IL-17-mediated inflammation. | 2019 | Details |
| A11592 | 30826497 | Life Sci | Interrelation of liver vascularity to non-alcoholic fatty liver through a comparative study of the vasodilator effect of carvedilol or nicorandil in rats. | 2019 | Details |
| A11601 | 30824190 | Biochem Biophys Res Commun | NLRC4 inflammasome activation regulated by TNF-α promotes inflammatory responses in nonalcoholic fatty liver disease. | 2019 | Details |
| A11604 | 30823334 | Environ Pollut | Environmental perfluoroalkyl acid exposures are associated with liver disease characterized by apoptosis and altered serum adipocytokines. | 2019 | Details |
| A11605 | 30822462 | Prog Lipid Res | Plant-based sterols and stanols in health & disease: "Consequences of human development in a plant-based environment?" | 2019 | Details |
| A11611 | 30820265 | World J Hepatol | Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects. | 2019 | Details |
| A11614 | 30819129 | BMC Cancer | Molecular Pathogenesis of Cholangiocarcinoma. | 2019 | Details |
| A11617 | 30818824 | Nutrients | A Pathophysiological Model of Non-Alcoholic Fatty Liver Disease Using Precision-Cut Liver Slices. | 2019 | Details |
| A11618 | 30818779 | Nutrients | Green Coffee Extract Improves Cardiometabolic Parameters and Modulates Gut Microbiota in High-Fat-Diet-Fed ApoE-/- Mice. | 2019 | Details |
| A11627 | 30813302 | Nutrients | The Relevance of Toxic AGEs (TAGE) Cytotoxicity to NASH Pathogenesis: A Mini-Review. | 2019 | Details |
| A11637 | 30809852 | J Cell Biochem | Preclinical study of the long-range safety and anti-inflammatory effects of high-dose oral meglumine. | 2019 | Details |
| A11638 | 30809789 | Semin Liver Dis | Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets. | 2019 | Details |
| A11640 | 30809151 | Front Physiol | LSEC Fenestrae Are Preserved Despite Pro-inflammatory Phenotype of Liver Sinusoidal Endothelial Cells in Mice on High Fat Diet. | 2019 | Details |
| A11646 | 30806344 | Br J Nutr | Spirulina supplementation in a mouse model of diet-induced liver fibrosis reduced the pro-inflammatory response of splenocytes. | 2019 | Details |
| A11647 | 30806308 | Curr Pharm Biotechnol | Phytosterols and Triterpenoids for Prevention and Treatment of Metabolic-related Liver Diseases and Hepatocellular Carcinoma. | 2019 | Details |
| A11648 | 30805986 | J Cell Biochem | Inhibition of TREM-1 attenuates inflammation and lipid accumulation in diet-induced nonalcoholic fatty liver disease. | 2019 | Details |
| A11651 | 30805370 | Biomed Res Int | Nonalcoholic Fatty Liver Disease Aggravated the Severity of Acute Pancreatitis in Patients. | 2019 | Details |
| A11661 | 30799179 | Nutr Metab Cardiovasc Dis | Betulinic acid inhibits high-fat diet-induced obesity and improves energy balance by activating AMPK. | 2019 | Details |
| A11665 | 30797053 | J Hepatol | Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease. | 2019 | Details |
| A11676 | 30793717 | Food Funct | Activated TNF-α/RIPK3 signaling is involved in prolonged high fat diet-stimulated hepatic inflammation and lipid accumulation: inhibition by dietary fisetin intervention. | 2019 | Details |
| A11679 | 30792450 | Sci Rep | Discovery of ((1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl)ureidyl derivatives as selective non-steroidal agonists of the G-protein coupled bile acid receptor-1. | 2019 | Details |
| A11680 | 30792163 | Arch Med Res | Therapeutic Intranasal Vaccine HB-ATV-8 Prevents Atherogenesis and Non-alcoholic Fatty Liver Disease in a Pig Model of Atherosclerosis. | 2019 | Details |
| A11698 | 30787925 | Front Immunol | The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity. | 2019 | Details |
| A11713 | 30781472 | Antioxidants (Basel) | Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview. | 2019 | Details |
| A11725 | 30775610 | Arch Med Sci Atheroscler Dis | Non-invasive diagnosis of steatosis, inflammatory changes and liver fibrosis in patients with non-alcoholic fatty liver diseases. Pilot study. | 2018 | Details |
| A11726 | 30774848 | Int J Prev Med | Effect of Vitamin D on Non-Alcoholic Fatty Liver Disease: A Systematic Review of Randomized Controlled Clinical Trials. | 2019 | Details |
| A11732 | 30772951 | J Cell Mol Med | Mesenteric adipose tissue B lymphocytes promote local and hepatic inflammation in non-alcoholic fatty liver disease mice. | 2019 | Details |
| A11734 | 30772256 | Mol Metab | Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice. | 2019 | Details |
| A11743 | 30769284 | Redox Biol | Electrophilic nitro-oleic acid reverses obesity-induced hepatic steatosis. | 2019 | Details |
| A11746 | 30767788 | BMC Res Notes | Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trial. | 2019 | Details |
| A11753 | 30765936 | J Clin Exp Hepatol | Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) as Serological Fibrosis Marker. | 2018 | Details |
| A11768 | 30759275 | Mol Genet Genomics | Molecular drivers of non-alcoholic steatohepatitis are sustained in mild-to-late fibrosis progression in a guinea pig model. | 2019 | Details |
| A11769 | 30758417 | Rev Assoc Med Bras (1992) | The efficacy of saxagliptin in T2DM patients with non-alcoholic fatty liver disease: preliminary data. | 2019 | Details |
| A11779 | 30747091 | Curr Mol Pharmacol | Activation of GLP-1 and Glucagon Receptors Regulates Bile Homeostasis Independent of Thyroid Hormone. | 2019 | Details |
| A11781 | 30746789 | Phytother Res | Coadministration of epigallocatechin-3-gallate (EGCG) and caffeine in low dose ameliorates obesity and nonalcoholic fatty liver disease in obese rats. | 2019 | Details |
| A11783 | 30745847 | Int J Biol Sci | Obesity, Nonalcoholic Fatty Liver Disease and Adipocytokines Network in Promotion of Cancer. | 2019 | Details |
| A11784 | 30745819 | Int J Biol Sci | Role of Nutrition in the Pathogenesis and Prevention of Non-alcoholic Fatty Liver Disease: Recent Updates. | 2019 | Details |
| A11785 | 30745809 | Int J Med Sci | Non-alcoholic fatty liver disease is associated with low-grade albuminuria in men without diabetes mellitus. | 2019 | Details |
| A11800 | 30735854 | Biochim Biophys Acta Mol Cell Biol Lipids | iPla2β deficiency in mice fed with MCD diet does not correct the defect of phospholipid remodeling but attenuates hepatocellular injury via an inhibition of lipid uptake genes. | 2019 | Details |
| A11806 | 30732555 | Eur J Sport Sci | Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): Roles of oxidative stress and inflammation. | 2019 | Details |
| A11808 | 30731283 | Atherosclerosis | Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps. | 2019 | Details |
| A11822 | 30720188 | Eur Rev Med Pharmacol Sci | Intestinal permeability in physiological and pathological conditions: major determinants and assessment modalities. | 2019 | Details |
| A11823 | 30720104 | Mol Med Rep | Tetramethylpyrazine reduces inflammation in the livers of mice fed a high fat diet. | 2019 | Details |
| A11831 | 30717085 | Nutrients | Weight Gain and Liver Steatosis in Patients with Inflammatory Bowel Diseases. | 2019 | Details |
| A11835 | 30714632 | Aliment Pharmacol Ther | Review article: shared disease mechanisms between non-alcoholic fatty liver disease and metabolic syndrome - translating knowledge from systems biology to the bedside. | 2019 | Details |
| A11836 | 30713255 | Biol Pharm Bull | Preventive Effect of Citrus aurantium Peel Extract on High-Fat Diet-Induced Non-alcoholic Fatty Liver in Mice. | 2019 | Details |
| A11849 | 30708111 | Clin Gastroenterol Hepatol | Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis. | 2019 | Details |
| A11856 | 30707092 | Nutr Res Rev | Interplay between early-life malnutrition, epigenetic modulation of the immune function and liver diseases. | 2019 | Details |
| A11862 | 30705687 | Nutr Metab (Lond) | Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial. | 2019 | Details |
| A11867 | 30703836 | Dtsch Med Wochenschr | [The Diabetic Heart and Heart Failure - Update on Mechanisms and Therapy]. | 2019 | Details |
| A11871 | 30701940 | Ter Arkh | The clinical significance of insulin resistance in non-diabetic patients with early forms of non-alcoholic fatty liver disease. | 2018 | Details |
| A11881 | 34267963 | Florence Nightingale Hemsire Derg | [Is There an Effect of Dietary Fructose on Development and Prognosis of Chronic Diseases?] | 2019 | Details |
| A11897 | 30689995 | Eur J Pharmacol | Betaine modulates oxidative stress, inflammation, apoptosis, autophagy, and Akt/mTOR signaling in methionine-choline deficiency-induced fatty liver disease. | 2019 | Details |
| A11901 | 30687994 | Diabetes Obes Metab | Efficacy of diacerein in reducing liver steatosis and fibrosis in patients with type 2 diabetes and non-alcoholic fatty liver disease: A randomized, placebo-controlled trial. | 2019 | Details |
| A11910 | 30684890 | Redox Biol | Adropin protects against liver injury in nonalcoholic steatohepatitis via the Nrf2 mediated antioxidant capacity. | 2018 | Details |
| A11916 | 30683312 | Biochem Biophys Res Commun | Liraglutide protects against inflammatory stress in non-alcoholic fatty liver by modulating Kupffer cells M2 polarization via cAMP-PKA-STAT3 signaling pathway. | 2019 | Details |
| A11917 | 30682878 | Medicina (Kaunas) | Oxidative Stress and Antioxidant Biomarkers in Clinical and Experimental Models of Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A11921 | 30681159 | J Inherit Metab Dis | Choline-related-inherited metabolic diseases-A mini review. | 2019 | Details |
| A11925 | 30680007 | Exp Ther Med | Effects of liver function, insulin resistance and inflammatory factors on vascular endothelial dilation function and prognosis of coronary heart disease patients complicated with NAFLD. | 2018 | Details |
| A11930 | 30677224 | Mol Nutr Food Res | Beneficial Effects of Pomegranate on Lipid Metabolism in Metabolic Disorders. | 2019 | Details |
| A11940 | 30673619 | Cell Rep | Impaired LXRα Phosphorylation Attenuates Progression of Fatty Liver Disease. | 2019 | Details |
| A11942 | 30673308 | Can J Physiol Pharmacol | The effect of cannabinoid receptor 1 blockade on adipokine and proinflammatory cytokine concentration in adipose and hepatic tissue in mice with nonalcoholic fatty liver disease. | 2019 | Details |
| A11946 | 30671174 | Oxid Med Cell Longev | Modulation of the Gut Microbiota in Rats by Hugan Qingzhi Tablets during the Treatment of High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A11948 | 30671098 | Lab Anim Res | The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2018 | Details |
| A11949 | 30670963 | Front Pharmacol | The Role of Nrf2 in Liver Disease: Novel Molecular Mechanisms and Therapeutic Approaches. | 2019 | Details |
| A11954 | 30669784 | Zhonghua Gan Zang Bing Za Zhi | [Interleukin-17-mediated inflammation promotes nonalcoholic fatty liver disease in mice with regulation of M1-type macrophage polarization]. | 2018 | Details |
| A11955 | 30669332 | Nutrients | Spirulina Liquid Extract Protects against Fibrosis Related to Non-Alcoholic Steatohepatitis and Increases Ursodeoxycholic Acid. | 2019 | Details |
| A11957 | 30668625 | Acta Biochim Biophys Sin (Shanghai) | Chronic intermittent hypoxia accelerates liver fibrosis in rats with combined hypoxia and nonalcoholic steatohepatitis via angiogenesis rather than endoplasmic reticulum stress. | 2019 | Details |
| A11968 | 30663454 | Scand J Gastroenterol | Predictive value of the red blood cell distribution width-to-platelet ratio for hepatic fibrosis. | 2019 | Details |
| A11970 | 30662331 | Int J Med Sci | Ultrasound/Elastography techniques, lipidomic and blood markers compared to Magnetic Resonance Imaging in non-alcoholic fatty liver disease adults. | 2019 | Details |
| A11974 | 30660825 | Pharmacol Res | Interactions between gut microbiota and non-alcoholic liver disease: The role of microbiota-derived metabolites. | 2019 | Details |
| A11978 | 30659956 | Exp Gerontol | Osthole inhibits oleic acid/lipopolysaccharide-induced lipid accumulation and inflammatory response through activating PPARα signaling pathway in cultured hepatocytes. | 2019 | Details |
| A11985 | 30658440 | Int J Mol Sci | Interactions between Host PPARs and Gut Microbiota in Health and Disease. | 2019 | Details |
| A11986 | 30658094 | Pharmacol Res | Intestinally derived bacterial products stimulate development of nonalcoholic steatohepatitis. | 2019 | Details |
| A12002 | 30652107 | Microb Cell | Imbalance in gut microbes from babies born to obese mothers increases gut permeability and myeloid cell adaptations that provoke obesity and NAFLD. | 2018 | Details |
| A12008 | 30647436 | Eur J Clin Nutr | A pilot study of the effect of phospholipid curcumin on serum metabolomic profile in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial. | 2019 | Details |
| A12017 | 30642098 | Microorganisms | Microbial Fermentation of Dietary Protein: An Important Factor in Diet⁻Microbe⁻Host Interaction. | 2019 | Details |
| A12021 | 30641412 | Mol Immunol | New Aspect of Liver IL-17+γδ T Cells. | 2019 | Details |
| A12037 | 30630288 | Biomol Ther (Seoul) | Integrative Omics Reveals Metabolic and Transcriptomic Alteration of Nonalcoholic Fatty Liver Disease in Catalase Knockout Mice. | 2019 | Details |
| A12043 | 30625517 | Biomed Pharmacother | A novel resveratrol-curcumin hybrid, a19, attenuates high fat diet-induced nonalcoholic fatty liver disease. | 2019 | Details |
| A12046 | 30625377 | Toxicol Lett | Thioacetamide potentiates high cholesterol and high fat diet induced steato-hepatitic changes in livers of C57BL/6J mice: A novel eight weeks model of fibrosing NASH. | 2019 | Details |
| A12051 | 30622377 | World J Gastroenterol | Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease. | 2018 | Details |
| A12060 | 30619336 | Front Immunol | Hepatocyte-Derived Lipotoxic Extracellular Vesicle Sphingosine 1-Phosphate Induces Macrophage Chemotaxis. | 2018 | Details |
| A12076 | 30611993 | Biomed Pharmacother | Plumbagin reduces obesity and nonalcoholic fatty liver disease induced by fructose in rats through regulation of lipid metabolism, inflammation and oxidative stress. | 2019 | Details |
| A12078 | 30611703 | Alcohol | Effect of nanoformulated copper/zinc superoxide dismutase on chronic ethanol-induced alterations in liver and adipose tissue. | 2019 | Details |
| A12081 | 30610213 | Eur J Clin Nutr | The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A12082 | 30609782 | Nutrients | Beneficial Effects of Vitamin D Treatment in an Obese Mouse Model of Non-Alcoholic Steatohepatitis. | 2019 | Details |
| A12089 | 30606929 | Yakugaku Zasshi | [A Multifaceted Approach regarding the Association of the DsbA-L Gene with the Risk of Obesity-related Diseases Based on Clinical Pharmacogenetics]. | 2019 | Details |
| A12108 | 30599260 | Free Radic Biol Med | Loss of RIP3 initiates annihilation of high-fat diet initialized nonalcoholic hepatosteatosis: A mechanism involving Toll-like receptor 4 and oxidative stress. | 2018 | Details |
| A12119 | 32422008 | Crit Rev Eukaryot Gene Expr | Current Update on Preclinical and Clinical Studies of Resveratrol, a Naturally Occurring Phenolic Compound. | 2020 | Details |
| A12122 | 30594305 | Cell Immunol | ER-stress regulates macrophage polarization through pancreatic EIF-2alpha kinase. | 2018 | Details |
| A12125 | 30592129 | IUBMB Life | Role of vitamin E in nonalcoholic fatty liver disease. | 2018 | Details |
| A12126 | 30591521 | EMBO Mol Med | The role of the microbiome in NAFLD and NASH. | 2019 | Details |
| A12132 | 30590049 | Cell Rep | OX40 Regulates Both Innate and Adaptive Immunity and Promotes Nonalcoholic Steatohepatitis. | 2018 | Details |
| A12135 | 30588564 | Drugs | Current and Emerging Therapies for Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A12140 | 30585337 | J Clin Pharm Ther | The effect of alpha-lipoic acid on inflammatory markers and body composition in obese patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial. | 2018 | Details |
| A12145 | 30582898 | Biochem Pharmacol | Developments in bile salt based therapies: A critical overview. | 2018 | Details |